Related Experiment Videos
Exchange transfusion for severe autoimmune hemolytic anemia
S M Heidemann1, S A Sarnaik, A P Sarnaik
1Children's Hospital of Michigan, Department of Pediatrics, Wayne State University School of Medicine, Detroit 48201.
The American Journal of Pediatric Hematology/Oncology
|January 1, 1987
Summary
Exchange transfusion effectively treated severe autoimmune hemolytic anemia (AIHA) in a child with heart failure when other methods failed. This procedure rapidly improved dangerously low hemoglobin levels, offering a vital treatment option for life-threatening anemia.
Area of Science:
- Pediatrics
- Hematology
- Immunology
Background:
- Autoimmune hemolytic anemia (AIHA) can lead to severe, life-threatening anemia.
- Standard treatments like corticosteroids and simple transfusions may be insufficient in critical cases.
- Pediatric AIHA presents unique challenges for managing severe hemolysis.
Observation:
- A 10-year-old patient with severe AIHA and heart failure experienced persistent, dangerously low hemoglobin levels.
- Multiple blood transfusions and corticosteroid therapy failed to adequately restore hemoglobin.
- A two-volume exchange transfusion was administered.
Findings:
- The exchange transfusion promptly restored and maintained satisfactory hemoglobin levels.
- This intervention effectively addressed the severe hemolysis and anemia.
- The patient's condition stabilized following the procedure.
Implications:
- Exchange transfusion is a viable and effective treatment for severe AIHA with life-threatening anemia, especially when conventional therapies fail.
- This method offers a critical alternative for pediatric patients where plasmapheresis may be technically challenging.
- Consideration of exchange transfusion in refractory AIHA can prevent severe complications like heart failure.